"Pleural Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Neoplasms of the thin serous membrane that envelopes the lungs and lines the thoracic cavity. Pleural neoplasms are exceedingly rare and are usually not diagnosed until they are advanced because in the early stages they produce no symptoms.
| Descriptor ID |
D010997
|
| MeSH Number(s) |
C04.588.894.797.640 C08.528.694 C08.785.640
|
| Concept/Terms |
Pleural Neoplasms- Pleural Neoplasms
- Neoplasms, Pleural
- Neoplasm, Pleural
- Pleural Neoplasm
|
Below are MeSH descriptors whose meaning is more general than "Pleural Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Pleural Neoplasms".
This graph shows the total number of publications written about "Pleural Neoplasms" by people in this website by year, and whether "Pleural Neoplasms" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1996 | 3 | 0 | 3 |
| 1997 | 1 | 1 | 2 |
| 1998 | 3 | 1 | 4 |
| 2000 | 3 | 0 | 3 |
| 2001 | 1 | 0 | 1 |
| 2002 | 1 | 1 | 2 |
| 2003 | 4 | 0 | 4 |
| 2004 | 5 | 1 | 6 |
| 2005 | 4 | 2 | 6 |
| 2006 | 7 | 0 | 7 |
| 2007 | 6 | 0 | 6 |
| 2008 | 6 | 1 | 7 |
| 2009 | 3 | 2 | 5 |
| 2010 | 6 | 0 | 6 |
| 2011 | 11 | 0 | 11 |
| 2012 | 6 | 0 | 6 |
| 2013 | 8 | 0 | 8 |
| 2014 | 4 | 0 | 4 |
| 2015 | 7 | 3 | 10 |
| 2016 | 7 | 0 | 7 |
| 2017 | 5 | 0 | 5 |
| 2018 | 7 | 0 | 7 |
| 2019 | 8 | 1 | 9 |
| 2020 | 1 | 0 | 1 |
| 2021 | 2 | 0 | 2 |
| 2023 | 2 | 0 | 2 |
| 2024 | 4 | 1 | 5 |
| 2025 | 0 | 1 | 1 |
Below are the most recent publications written about "Pleural Neoplasms" by people in Profiles.
-
Protocol summary of a randomized phase III study: comparing systemic therapy with and without debulking surgery (primary tumour resection) for clinical stage IVA (cT1-2bN0-1M1a) non-small cell lung cancer with radiologically undetermined pleural dissemination JCOG2103 (DEBULK-LUNG). Jpn J Clin Oncol. 2025 Feb 04; 55(2):176-182.
-
American Association of Bronchology and Interventional Pulmonology Essential Knowledge in Interventional Pulmonology Series: Selected Topics in Malignant Pleural Disease. J Bronchology Interv Pulmonol. 2025 Jan 01; 32(1).
-
Randomized trial of anetumab ravtansine and pembrolizumab compared to pembrolizumab for mesothelioma. Lung Cancer. 2024 Sep; 195:107928.
-
Pegargiminase Plus First-Line Chemotherapy in Patients With Nonepithelioid Pleural Mesothelioma: The ATOMIC-Meso Randomized Clinical Trial. JAMA Oncol. 2024 Apr 01; 10(4):475-483.
-
NCCN Guidelines® Insights: Mesothelioma: Pleural, Version 1.2024. J Natl Compr Canc Netw. 2024 03; 22(2):72-81.
-
Overdiagnosis of diffuse mesothelioma: A reminder that pathologists need to think outside the "immunohistochemistry diagnostic box". Ann Diagn Pathol. 2024 Feb; 68:152264.
-
Short Report of a Phase II Trial of Nintedanib in Recurrent Malignant Pleural Mesothelioma (MPM). Clin Lung Cancer. 2023 09; 24(6):563-567.
-
Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity. Nat Genet. 2023 04; 55(4):607-618.
-
Comparison of Nuclear Grade, Necrosis, and Histologic Subtype Between Biopsy and Resection in Pleural Malignant Mesothelioma: An International Multi-Institutional Analysis. Am J Clin Pathol. 2021 Nov 08; 156(6):989-999.
-
Strike or Spare? A Review of Lung-Sparing Therapies for Malignant Pleural Mesothelioma. Int J Radiat Oncol Biol Phys. 2021 06 01; 110(2):257-260.